NYSE - Nasdaq Real Time Price USD

Stryker Corporation (SYK)

338.00

+0.85

(+0.25%)

As of 12:31 PM EDT. Market Open.

Analysts Estimate Agios Pharmaceuticals (AGIO) to Report a Decline in Earnings: What to Look Out for

Agios Pharmaceuticals (AGIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks yesterday

AGIO

SYK
+0.25%
Seeking Clues to Stryker (SYK) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics

Evaluate the expected performance of Stryker (SYK) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Zacks yesterday

SYK
+0.25%
SYK vs ZBH: Which Stock Looks More Promising Ahead of Q1 Earnings?

SYK and ZBH are expected to have witnessed strong procedural volume growth across the global market in the first quarter.

Zacks yesterday

SYK
+0.25%
ZBH
-0.31%
What Makes Stryker Corporation (SYK) an Investment Choice?

Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The fund advanced 8.92% (Institutional Shares) in the quarter compared to an 8.52% gain for the Russell 3000 Health Care Index (benchmark) and a 10.56% increase for the S&P […]

Insider Monkey 2 days ago

SYK
+0.25%
Does Stryker (NYSE:SYK) Deserve A Spot On Your Watchlist?

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Simply Wall St. 2 days ago

SYK
+0.25%
Ongoing Procedural Growth May Aid Stryker's (SYK) Q1 Earnings

Stryker's (SYK) first-quarter 2024 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued to hurt margins.

Zacks 2 days ago

SYK
+0.25%
EW
-1.40%
CAH
Stryker (SYK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 3 days ago

SYK
+0.25%
RMD
This CEO has battled billionaire activist Carl Icahn twice — here's his advice to Disney CEO Bob Iger

Illumina chairman and Hologic CEO Stephen MacMillan is no stranger to dealing with well-known activist investors.

Yahoo Finance 5 days ago

ILMN

SYK
+0.25%
DIS
3 Robotics Stocks to Turn $1000 into $1 Million: April 2024

Robotics and related technologies, such as workflow automation products, cloud services, and generative AI technology, have captivated the investing community. They have assisted in leading the overall market higher over this past year especially. Investors are very interested in technology companies focused on innovation and the rollout of brand-new products and services. With the technology sector booming, it’s a perfect time for investors to jump into these robotics companies with a great fut

InvestorPlace 8 days ago

PATH

SYM

SYK
+0.25%
Henry Schein (HSIC) Global Presence Aids, Macroeconomic Woes Stay

Henry Schein (HSIC) is busy promoting digital workflows for general dentistry and dental specialties.

Zacks 9 days ago

HSIC

DVA

SYK
+0.25%
Here's Why You Should Retain Chemed (CHE) Stock for Now

Investors are optimistic about Chemed (CHE), backed by the strong performance of the VITAS Healthcare and Roto-Rooter segments.

Zacks 9 days ago

CHE

SYK
+0.25%
DVA
Here's Why You Should Retain Charles River (CRL) Stock Now

Investors are optimistic about Charles River (CRL) owing to strength in RMS and DSA segments.

Zacks 10 days ago

CRL

SYK
+0.25%
CAH
Bio-Rad (BIO) Hurt by Softness in BioPharma and Competition

Bio-Rad's (BIO) margin performance bears the brunt of elevated raw material costs, increased logistics costs and higher employee-related expenses.

Zacks 10 days ago

BIO-B

SYK
+0.25%
DVA
Institutional investors in Stryker Corporation (NYSE:SYK) lost 3.0% last week but have reaped the benefits of longer-term growth

Key Insights Institutions' substantial holdings in Stryker implies that they have significant influence over the...

Simply Wall St. 10 days ago

SYK
+0.25%
Hologic's (HOLX) New Launches Aid, Macroeconomic Issues Ail

Hologic's (HOLX) Breast Health segment is gaining from a broad portfolio of solutions for breast cancer care, primarily in the burgeoning spaces of radiology, breast surgery, pathology and treatment.

Zacks 14 days ago

HOLX

SYK
+0.25%
CAH
Smith+Nephew (SNN) Expands in Australia With New Alliance

The latest partnership allows Smith+Nephew (SNN) to complement its existing implant range with the cutting-edge navigation technology of NAVBIT.

Zacks 15 days ago

ZBH
-0.31%
SYK
+0.25%
CNMD
Align Technology (ALGN) Up 20.5% YTD: Will the Rally Continue?

Investors are optimistic about Align Technology (ALGN) driven by geographic expansion and upbeat guidance.

Zacks 16 days ago

ALGN

SYK
+0.25%
CAH
Boston Scientific (BSX) Faces Rising Costs, Competition

With Boston Scientific (BSX) recording 40% of its sales from the international market, it remains highly exposed to currency fluctuations.

Zacks 16 days ago

BSX
-0.03%
SYK
+0.25%
Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now

Investors are optimistic about Myriad Genetics' (MYGN) strong solvency position and improvement in testing volume.

Zacks 17 days ago

MYGN

CAH

SYK
+0.25%
Labcorp's (LH) Strategic Alliances Aid Amid Macroeconomic Woes

Labcorp (LH) is investing in innovation and technology that supports diagnostic and drug development testing for various diseases such as cancer and Alzheimer's.

Zacks 17 days ago

LH

DVA

SYK
+0.25%

Performance Overview

Return	SYK	S&P 500
YTD	+13.13%	+7.00%
1-Year	+14.03%	+25.35%
3-Year	+30.82%	+22.09%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Stryker Corporation (SYK)

Analysts Estimate Agios Pharmaceuticals (AGIO) to Report a Decline in Earnings: What to Look Out for

Seeking Clues to Stryker (SYK) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics

SYK vs ZBH: Which Stock Looks More Promising Ahead of Q1 Earnings?

What Makes Stryker Corporation (SYK) an Investment Choice?

Does Stryker (NYSE:SYK) Deserve A Spot On Your Watchlist?

Ongoing Procedural Growth May Aid Stryker's (SYK) Q1 Earnings

Stryker (SYK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

This CEO has battled billionaire activist Carl Icahn twice — here's his advice to Disney CEO Bob Iger

3 Robotics Stocks to Turn $1000 into $1 Million: April 2024

Henry Schein (HSIC) Global Presence Aids, Macroeconomic Woes Stay

Here's Why You Should Retain Chemed (CHE) Stock for Now

Here's Why You Should Retain Charles River (CRL) Stock Now

Bio-Rad (BIO) Hurt by Softness in BioPharma and Competition

Institutional investors in Stryker Corporation (NYSE:SYK) lost 3.0% last week but have reaped the benefits of longer-term growth

Hologic's (HOLX) New Launches Aid, Macroeconomic Issues Ail

Smith+Nephew (SNN) Expands in Australia With New Alliance

Align Technology (ALGN) Up 20.5% YTD: Will the Rally Continue?

Boston Scientific (BSX) Faces Rising Costs, Competition

Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now

Labcorp's (LH) Strategic Alliances Aid Amid Macroeconomic Woes

Performance Overview